These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19006613)

  • 1. Recent advances in IBD pathogenesis: genetics and immunobiology.
    Shih DQ; Targan SR; McGovern D
    Curr Gastroenterol Rep; 2008 Dec; 10(6):568-75. PubMed ID: 19006613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into IBD Pathogenesis.
    Shih DQ; Targan SR
    Curr Gastroenterol Rep; 2009 Dec; 11(6):473-80. PubMed ID: 19903423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on genetics in inflammatory disease.
    Noomen CG; Hommes DW; Fidder HH
    Best Pract Res Clin Gastroenterol; 2009; 23(2):233-43. PubMed ID: 19414149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of inflammatory bowel disease: current concepts.
    Bamias G; Cominelli F
    Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-23/IL-17 axis in IBD.
    Sarra M; Pallone F; Macdonald TT; Monteleone G
    Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune aspects of the pathogenesis of inflammatory bowel disease.
    Hisamatsu T; Kanai T; Mikami Y; Yoneno K; Matsuoka K; Hibi T
    Pharmacol Ther; 2013 Mar; 137(3):283-97. PubMed ID: 23103332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The innate immune system and inflammatory bowel disease.
    Davies JM; Abreu MT
    Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region: no association with inflammatory bowel disease.
    Büning C; Genschel J; Weltrich R; Lochs H; Schmidt H
    Eur J Immunogenet; 2003 Oct; 30(5):329-33. PubMed ID: 14641539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics and immunopathogenesis of inflammatory bowel disease.
    Cho JH
    Nat Rev Immunol; 2008 Jun; 8(6):458-66. PubMed ID: 18500230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease: beyond the boundaries of the bowel.
    Actis GC; Rosina F; Mackay IR
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease.
    Zhou M; He J; Shen Y; Zhang C; Wang J; Chen Y
    Biomed Res Int; 2017; 2017():8201672. PubMed ID: 28831399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease: pathogenesis.
    Zhang YZ; Li YY
    World J Gastroenterol; 2014 Jan; 20(1):91-9. PubMed ID: 24415861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis.
    Parkes M
    Dig Dis; 2012; 30(4):330-3. PubMed ID: 22796792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity.
    Hildner K; Punkenburg E; Abendroth B; Neurath MF
    Dig Dis; 2016; 34 Suppl 1():40-7. PubMed ID: 27548324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease.
    Khan S; Imran A; Malik A; Chaudhary AA; Rub A; Jan AT; Syed JB; Rolfo C
    Crit Rev Clin Lab Sci; 2019 Jan; 56(1):1-17. PubMed ID: 30373492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease.
    Verstockt B; Van Assche G; Vermeire S; Ferrante M
    Expert Opin Biol Ther; 2017 Jan; 17(1):31-47. PubMed ID: 27817215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.